AI assistant
MASIMO CORP — Director's Dealing 2023
Aug 10, 2023
30755_dirs_2023-08-10_4ff3b82f-9407-4c18-b701-d95680595cdd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Neuraxis, INC (NRXS)
CIK: 0001933567
Period of Report: 2023-08-10
Reporting Person: MASIMO CORP (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-10 | Common Stock | C | 531548 | — | Acquired | 531548 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-08-10 | Series A Preferred Stock | $ | C | 265774 | Disposed | Common Stock (531548.0) | Direct | |
| 2023-08-10 | Pre-Funded Warrant, Series A Preferred Stock (Right to Buy) | $0.0001 | C | 144890 | Disposed | Series A Preferred Stock (144890.0) | Direct | |
| 2023-08-10 | Pre-Funded Warrant, Common Stock (Right to Buy) | $0.0005 | C | 289779 | Acquired | Common Stock (289779.0) | Direct |
Footnotes
F1: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date.
F2: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock.